谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 24 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The Evolvement of Breast Cancer Therapies
Ika Nurlaila,Sabar Pambudi
Saudi medical journalno. 4 (2024): 331-340
引用0浏览0引用
0
0
Human Mammary Tumor Virus (HMTV) Reshapes Risk of Women Developing Breast Cancer: Re-visiting an under Considered Variable in Tumorigenesis of the Breast
Ika Nurlaila, Astutiati Nurhasanah
Asian Pacific journal of cancer prevention APJCPno. 1 (2024): 1-2
引用0浏览0WOS引用
0
0
The Silent Threat of Interplay Between Immune Checkpoint Inhibitors and Herbal Medicines
Ika Nurlaila
Asian Pacific journal of cancer prevention APJCPno. 10 (2024): 3337-3338
引用0浏览0WOS引用
0
0
Development of Mouse Monoclonal Antibody Anti-Ag85B Protein of Mycobacterium Tuberculosis
Sabar Pambudi,Tika Widayanti,Febby N. Ningsih,Asri Sulfianti,Jodi Suryanggono,Ika Nurlaila
Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022)pp.149-157, (2023)
引用0浏览0引用
0
0
Immune Checkpoints: The Rising Branch in Cancer Immunotherapy
Ika Nurlaila
Immune Checkpoint Inhibitors - New Insights and Recent Progress (2023)
引用0浏览0引用
0
0
Peer-Review Statements
Ika Nurlaila,Novaria S. D. Panjaitan, Rosantia Sarassari,Rika Rachmalina, Hayani Anastasia,Yunefit Ulfa,Gurendro Putro,Sela S. Mariya, Anna L. Poetranto,Rozana I. Agustiya
Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022)pp.1-4, (2023)
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 23

#Citation: 38

H-Index: 4

G-Index: 5

Sociability: 4

Diversity: 1

Activity: 3

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn